Conclusions
MIS-C has overlapping clinical and laboratory features highlighting the
added difficult challenge of diagnosing EVALI during the COVID-19
pandemic. We stress the importance of a through history and possible
drug screening when COVID-19 testing is negative in concerning clinical
presentations.